SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+11.0%
5Y CAGR+9.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+11.0%/yr
vs +7.6%/yr prior
5Y CAGR
+9.5%/yr
Consistent
Acceleration
+3.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
9 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$100.51B+5.8%
2024$95.02B+13.7%
2023$83.55B+13.6%
2022$73.54B+6.5%
2021$69.04B+7.9%
2020$63.99B+4.8%
2019$61.03B+11.3%
2018$54.81B+9.0%
2017$50.28B+2.5%
2016$49.08B-